Form 8-K - Current report:
SEC Accession No. 0001683168-25-001124
Filing Date
2025-02-19
Accepted
2025-02-19 17:10:07
Documents
15
Period of Report
2025-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT odyssey_8k.htm   iXBRL 8-K 25854
2 AMENDMENT NO. 3 TO PROMISSORY NOTE WITH JON LUTZ odyssey_ex1001.htm EX-10.1 3538
3 AMENDMENT NO. 9 TO CONVERTIBLE PROMISSORY NOTE WITH LGH INVESTMENTS, LLC odyssey_ex1002.htm EX-10.2 11045
  Complete submission text file 0001683168-25-001124.txt   217496

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE odyy-20250213.xsd EX-101.SCH 3075
5 XBRL LABEL FILE odyy-20250213_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE odyy-20250213_pre.xml EX-101.PRE 24205
17 EXTRACTED XBRL INSTANCE DOCUMENT odyssey_8k_htm.xml XML 3475
Mailing Address 2300 WEST SAHARA AVENUE SUITE 800-#4012 LAS VEGAS NV 89102
Business Address 2300 WEST SAHARA AVENUE SUITE 800-#4012 LAS VEGAS NV 89102 702-780-6559
Odyssey Health, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56196 | Film No.: 25641588
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)